... The exclusion criteria were heterogeneous and included pregnancy [27,46,47,53,[59][60][61]63,71,74,82,83,86,88,98], neurological diseases [29,35,37,39,41,44,62,65,77,81,82,84,97], rheumatic diseases [29,32,33,39,[41][42][43][44]47,55,[57][58][59][60]65,74,77,79,80,83,88,91,94,98], psychological/psychiatric conditions [27,32,38,42,45,46,49,50,55,[59][60][61]63,64,66,69,70,[73][74][75][79][80][81][82][83]89,91,94], intake medication [32,35,41,44,49,54,57,58,64,66,75,95], diabetes mellitus [32,43,44,55,57,58,65,85], cancer [32,34,46,58,64,67,82,89], skin disorders [29,[50][51][52]92], trauma [59-61, 65,83,92], hypertension [32,[42][43][44]57,58,65,66,72], migraine [59][60][61]83], osteoarthritis [30,43,66,85,91], peripheral nerve entrapment [59][60][61]83], obesity [29,39,74], substance abuse [64,73,77], and hypotension [50,51,65]. It is important to mention that in 54.7% (n = 40/73) of clinical trials, people with cardiac, pulmonary or kidney diseases were excluded since these "visceral" conditions could limit the therapeutic intervention used in these trials (exercise). ...